PT1244625E - 4-piridinil-n-acil-l-fenilalaninas - Google Patents

4-piridinil-n-acil-l-fenilalaninas

Info

Publication number
PT1244625E
PT1244625E PT00985117T PT00985117T PT1244625E PT 1244625 E PT1244625 E PT 1244625E PT 00985117 T PT00985117 T PT 00985117T PT 00985117 T PT00985117 T PT 00985117T PT 1244625 E PT1244625 E PT 1244625E
Authority
PT
Portugal
Prior art keywords
phenylalanins
pyridinyl
acyl
Prior art date
Application number
PT00985117T
Other languages
English (en)
Inventor
Jefferson Wright Tilley
Achytharao Sidduri
Kaplan Gerald Lewis
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT1244625E publication Critical patent/PT1244625E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT00985117T 1999-12-06 2000-11-29 4-piridinil-n-acil-l-fenilalaninas PT1244625E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16909099P 1999-12-06 1999-12-06

Publications (1)

Publication Number Publication Date
PT1244625E true PT1244625E (pt) 2005-09-30

Family

ID=22614226

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00985117T PT1244625E (pt) 1999-12-06 2000-11-29 4-piridinil-n-acil-l-fenilalaninas

Country Status (34)

Country Link
EP (1) EP1244625B1 (pt)
JP (2) JP2003516392A (pt)
KR (1) KR100492111B1 (pt)
CN (1) CN1196682C (pt)
AR (1) AR031083A1 (pt)
AT (1) ATE297895T1 (pt)
AU (1) AU779063B2 (pt)
BR (1) BR0016172A (pt)
CA (1) CA2392566A1 (pt)
CO (1) CO5080771A1 (pt)
CZ (1) CZ20022352A3 (pt)
DE (1) DE60020883T2 (pt)
DK (1) DK1244625T3 (pt)
ES (1) ES2243335T3 (pt)
GC (1) GC0000214A (pt)
HK (1) HK1053470A1 (pt)
HR (1) HRP20020467A2 (pt)
HU (1) HUP0203735A3 (pt)
IL (2) IL149622A0 (pt)
JO (1) JO2281B1 (pt)
MA (1) MA26849A1 (pt)
MX (1) MXPA02005240A (pt)
MY (1) MY128003A (pt)
NO (1) NO322910B1 (pt)
NZ (1) NZ518888A (pt)
PE (1) PE20010960A1 (pt)
PL (1) PL364814A1 (pt)
PT (1) PT1244625E (pt)
RU (1) RU2270193C2 (pt)
TW (1) TWI276629B (pt)
UY (1) UY26470A1 (pt)
WO (1) WO2001042215A1 (pt)
YU (1) YU40502A (pt)
ZA (1) ZA200203762B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960597B2 (en) 2000-06-30 2005-11-01 Orth-Mcneil Pharmaceutical, Inc. Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
CZ302653B6 (cs) 2000-08-18 2011-08-17 Ajinomoto Co., Inc. Fenylalaninové deriváty, alfa-4-integrinový antagonist, terapeutické cinidlo nebo preventivní cinidlo a farmaceutický prostredek obsahující tyto deriváty
EP1323711B1 (en) * 2000-09-29 2006-11-15 Ajinomoto Co., Inc. Novel phenylalanine derivatives
EP1454898A4 (en) 2001-12-13 2006-12-13 Ajinomoto Kk NEW PHENYL ALANIDE DERIVATIVES
EP1465869B1 (en) 2001-12-21 2013-05-15 Exelixis Patent Company LLC Modulators of lxr
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
ES2548853T3 (es) 2003-12-22 2015-10-21 Ajinomoto Co., Inc. Derivado de fenilalanina
US7618981B2 (en) * 2004-05-06 2009-11-17 Cytokinetics, Inc. Imidazopyridinyl-benzamide anti-cancer agents
JP4649476B2 (ja) * 2004-08-16 2011-03-09 メルク・シャープ・エンド・ドーム・コーポレイション Vla−4拮抗薬
JP4784224B2 (ja) 2004-09-24 2011-10-05 味の素株式会社 糖鎖転移方法および糖鎖転移酵素
WO2007100763A2 (en) * 2006-02-28 2007-09-07 Elan Pharmaceuticals, Inc. Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds
AR060901A1 (es) * 2006-05-12 2008-07-23 Jerini Ag Compuestos heterociclicos para la inhibicion de integrinas y uso de estos
US20100150915A1 (en) 2007-02-20 2010-06-17 Stewart Edward J Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
ES2525065T3 (es) 2008-04-11 2014-12-17 Merrimack Pharmaceuticals, Inc. Ligadores de seroalbúmina humana y sus conjugados
BR112012001558A2 (pt) * 2009-07-23 2016-03-08 Bayer Cropscience Ag alcoxienonas e enaminocetonas e um processo para a sua preparação
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
CN104023751B (zh) * 2012-01-27 2016-11-09 弗·哈夫曼-拉罗切有限公司 靶向递送至表达vla-4的细胞的整联蛋白拮抗剂结合物
CA2913791A1 (en) * 2013-06-11 2014-12-18 Receptos, Inc. Novel glp-1 receptor modulators
AU2017214589B2 (en) 2016-02-05 2020-09-03 Ea Pharma Co., Ltd. Sulfonamide derivative and pharmaceutical composition containing same
CA3114240C (en) 2018-10-30 2023-09-05 Gilead Sciences, Inc. Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
SG11202103484RA (en) 2018-10-30 2021-05-28 Gilead Sciences Inc Quinoline derivatives as alpha4beta7 integrin inhibitors
CN112969504B (zh) 2018-10-30 2024-04-09 吉利德科学公司 用于抑制α4β7整合素的化合物
JP7189368B2 (ja) 2018-10-30 2022-12-13 ギリアード サイエンシーズ, インコーポレイテッド アルファ4ベータ7インテグリンの阻害のための化合物
CA3148613A1 (en) 2019-08-14 2021-02-18 Gilead Sciences, Inc. Phenylalanine derived compounds and their use as inhinitors of alpha 4 beta 7 integrin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002512625A (ja) * 1997-05-29 2002-04-23 メルク エンド カンパニー インコーポレーテッド 細胞接着阻害薬としての複素環アミド化合物
JP2001517245A (ja) * 1997-05-29 2001-10-02 メルク エンド カンパニー インコーポレーテッド 細胞接着阻害薬としてのビアリールアルカン酸類
US6197794B1 (en) * 1998-01-08 2001-03-06 Celltech Therapeutics Limited Phenylalanine derivatives
MY153569A (en) * 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
US6329372B1 (en) * 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
ES2226413T3 (es) * 1998-02-26 2005-03-16 Celltech Therapeutics Limited Derivados de fenilalanina como inhibidores de alfa-4 integrinas.
GB9811159D0 (en) * 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
ATE261932T1 (de) * 1998-12-22 2004-04-15 Tanabe Seiyaku Co Inhibitoren der alpha-4 beta-1 vermittelten zelladhäsion
CN1231212C (zh) * 1999-01-22 2005-12-14 依兰制药公司 抑制vla-4介导的白细胞粘着的多环化合物

Also Published As

Publication number Publication date
AU779063B2 (en) 2005-01-06
JO2281B1 (en) 2005-09-12
YU40502A (sh) 2005-03-15
HUP0203735A2 (hu) 2003-03-28
UY26470A1 (es) 2001-05-31
KR20020060256A (ko) 2002-07-16
IL149622A (en) 2006-12-10
ZA200203762B (en) 2004-01-28
DE60020883D1 (de) 2005-07-21
CA2392566A1 (en) 2001-06-14
MA26849A1 (fr) 2004-12-20
NZ518888A (en) 2004-02-27
WO2001042215A1 (en) 2001-06-14
CN1402709A (zh) 2003-03-12
TWI276629B (en) 2007-03-21
AU2163901A (en) 2001-06-18
EP1244625A1 (en) 2002-10-02
GC0000214A (en) 2006-03-29
MY128003A (en) 2007-01-31
PE20010960A1 (es) 2001-09-22
AR031083A1 (es) 2003-09-10
JP2008094842A (ja) 2008-04-24
ATE297895T1 (de) 2005-07-15
JP2003516392A (ja) 2003-05-13
NO20022650L (no) 2002-06-05
PL364814A1 (en) 2004-12-13
DE60020883T2 (de) 2006-03-23
MXPA02005240A (es) 2002-11-07
BR0016172A (pt) 2002-08-20
NO20022650D0 (no) 2002-06-05
KR100492111B1 (ko) 2005-06-01
HK1053470A1 (en) 2003-10-24
CN1196682C (zh) 2005-04-13
CZ20022352A3 (cs) 2003-05-14
RU2270193C2 (ru) 2006-02-20
HRP20020467A2 (en) 2004-04-30
HUP0203735A3 (en) 2005-03-29
EP1244625B1 (en) 2005-06-15
DK1244625T3 (da) 2005-10-10
ES2243335T3 (es) 2005-12-01
IL149622A0 (en) 2002-11-10
CO5080771A1 (es) 2001-09-25
NO322910B1 (no) 2006-12-18

Similar Documents

Publication Publication Date Title
DE50010505D1 (de) Gurtaufrollersystem
DE122007000064I1 (de) Erythropoietinkonjugate
DE19983871T1 (de) Fönvorrichtung
DE10084676T1 (de) Einmallanzettvorrichtung
DE50002834D1 (de) Handstempel
DK1244625T3 (da) 4-pyridinyl-n-acyl-l-phenylalaniner
DE59909346D1 (de) Zylinderkopfdichtung
DE50007953D1 (de) Beleuchtungsanordung
DE50015451D1 (de) Spülwannensystem
DE59910286D1 (de) Kniehebel-spannvorrichtung
DE50009570D1 (de) Wechselcorrugator
DE50016100D1 (de) Gabtriebs
DE50008613D1 (de) Sicherungsring
DE50000805D1 (de) Aufsitzspanner
DE60000107D1 (de) Formschliessvorrichtung
DE50006899D1 (de) Antistatikum
DE10085008T1 (de) Oberflächenbehandlungsdüse
DE50003660D1 (de) Diacylhydrazinderivate
DE50012482D1 (de) Tibiamarknagel
DE50006013D1 (de) Anschlagpuffer
DE50003259D1 (de) Textilie
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
DE50008429D1 (de) Kraftstofffraktioniereinrichtung
DE50001640D1 (de) Nahfeldoptische untersuchungsvorrichtung
DE50006759D1 (de) Piperidinalkohole